Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix' Shares Down 7 Percent on Q4 Revenue Slide

NEW YORK (GenomeWeb News) — Shares in CombiMatrix were down 7 percent at $.76 in mid-afternoon trading after the company this morning reported dismal fourth-quarter results.
 
As GenomeWeb News reported this morning, the Acacia unit said fourth-quarter revenues fell 76 percent and losses more than doubled year over year.
The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.